大博医疗收盘下跌7.36%，滚动市盈率59.57倍，总市值237.19亿元

Core Viewpoint - Dabo Medical's stock closed at 57.29 yuan on August 14, experiencing a decline of 7.36%, with a rolling PE ratio of 59.57 times and a total market capitalization of 23.719 billion yuan [1] Company Summary - Dabo Medical specializes in the production, research, and sales of high-value medical consumables, with key products including intramedullary nails, hollow nails, ordinary plates, locking plates, external fixators, bone needles, spinal fixation devices, and various joint prostheses [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 550 million yuan, a year-on-year increase of 28.80%, and a net profit of 103 million yuan, a year-on-year increase of 67.04%, with a gross profit margin of 69.64% [1] Industry Summary - The average PE ratio for the medical device industry is 55.76 times, with a median of 39.14 times, placing Dabo Medical at the 90th position in the industry ranking [1] - The company’s PE (TTM) is 59.57, while the industry average is 55.76, indicating that Dabo Medical is trading at a premium compared to its peers [2] - The total market capitalization of Dabo Medical is 23.719 billion yuan, which is significantly higher than the industry median market capitalization of 5.679 billion yuan [2]